Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2015

Open Access 01-12-2015 | Research article

Strategies for monitoring and evaluation of resource-limited national antiretroviral therapy programs: the two-phase design

Authors: Sebastien Haneuse, Bethany Hedt-Gauthier, Frank Chimbwandira, Simon Makombe, Lyson Tenthani, Andreas Jahn

Published in: BMC Medical Research Methodology | Issue 1/2015

Login to get access

Abstract

Background

In resource-limited settings, monitoring and evaluation (M&E) of antiretroviral treatment (ART) programs often relies on aggregated facility-level data. Such data are limited, however, because of the potential for ecological bias, although collecting detailed patient-level data is often prohibitively expensive. To resolve this dilemma, we propose the use of the two-phase design. Specifically, when the outcome of interest is binary, the two-phase design provides a framework within which researchers can resolve ecological bias through the collection of patient-level data on a sub-sample of individuals while making use of the routinely collected aggregated data to obtain potentially substantial efficiency gains.

Methods

Between 2005–2007, the Malawian Ministry of Health conducted a one-time cross-sectional survey of 82,887 patients registered at 189 ART clinics. Using these patient data, an aggregated dataset is constructed to mimic the type of data that it routinely available. A hypothetical study of risk factors for patient outcomes at 6 months post-registration is considered. Analyses are conducted based on: (i) complete patient-level data; (ii) aggregated data; (iii) a hypothetical case–control study; (iv) a hypothetical two-phase study stratified on clinic type; and, (v) a hypothetical two-phase study stratified on clinic type and registration year. A simulation study is conducted to compare statistical power to detect an interaction between clinic type and year of registration across the designs.

Results

Analyses and conclusions based solely on aggregated data may suffer from ecological bias. Collecting and analyzing patient data using either a case–control or two-phase design resolves ecological bias to provide valid conclusions. To detect the interaction between clinic type and year of registration, the case–control design would require a prohibitively large sample size. In contrast, a two-phase design that stratifies on clinic and year of registration achieves greater than 85% power with as few as 1,000 patient samples.

Conclusions

Two-phase designs have the potential to augment current M&E efforts in resource-limited settings by providing a framework for the collection and analysis of patient data. The design is cost-efficient in the sense that it often requires far fewer patients to be sampled when compared to standard designs.
Literature
1.
go back to reference Lowrance D, Filler S, Makombe S, Harries A, Aberle-Grasse J, Hochgesang M, et al. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health. 2007;12(3):377–81.CrossRefPubMed Lowrance D, Filler S, Makombe S, Harries A, Aberle-Grasse J, Hochgesang M, et al. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health. 2007;12(3):377–81.CrossRefPubMed
2.
go back to reference Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet. 2006;367(9519):1335–42.CrossRefPubMed Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet. 2006;367(9519):1335–42.CrossRefPubMed
3.
go back to reference Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, Furrer H, et al. Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared. PLoS Med. 2008;5(7):e148.CrossRefPubMedPubMedCentral Keiser O, Orrell C, Egger M, Wood R, Brinkhof MW, Furrer H, et al. Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared. PLoS Med. 2008;5(7):e148.CrossRefPubMedPubMedCentral
4.
go back to reference Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS. 2008;22(7):873–82.CrossRefPubMedPubMedCentral Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d’Ivoire: 2-year outcomes and determinants. AIDS. 2008;22(7):873–82.CrossRefPubMedPubMedCentral
5.
go back to reference Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Van Rie A. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: A prospective cohort study. J Int AIDS Soc. 2009;12:38.CrossRefPubMedPubMedCentral Sanne IM, Westreich D, Macphail AP, Rubel D, Majuba P, Van Rie A. Long term outcomes of antiretroviral therapy in a large HIV/AIDS care clinic in urban South Africa: A prospective cohort study. J Int AIDS Soc. 2009;12:38.CrossRefPubMedPubMedCentral
6.
go back to reference Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke GS, Newell ML. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: Does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88(8):593–600.CrossRefPubMedPubMedCentral Mutevedzi PC, Lessells RJ, Heller T, Barnighausen T, Cooke GS, Newell ML. Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: Does rapid expansion affect patient outcomes? Bull World Health Organ. 2010;88(8):593–600.CrossRefPubMedPubMedCentral
7.
8.
go back to reference Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, et al. True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007;85(7):550–4.CrossRefPubMedPubMedCentral Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, et al. True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ. 2007;85(7):550–4.CrossRefPubMedPubMedCentral
9.
go back to reference Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC, et al. Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J Epidemiol. 2009;38(3):746–56.CrossRefPubMedPubMedCentral Chi BH, Cantrell RA, Zulu I, Mulenga LB, Levy JW, Tambatamba BC, et al. Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. Int J Epidemiol. 2009;38(3):746–56.CrossRefPubMedPubMedCentral
10.
go back to reference Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, et al. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clin Infect Dis. 2009;48(9):1318–22.CrossRefPubMed Kouanfack C, Montavon C, Laurent C, Aghokeng A, Kenfack A, Bourgeois A, et al. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Clin Infect Dis. 2009;48(9):1318–22.CrossRefPubMed
11.
go back to reference Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53(3):405–11.CrossRefPubMedPubMedCentral Geng EH, Bangsberg DR, Musinguzi N, Emenyonu N, Bwana MB, Yiannoutsos CT, et al. Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr. 2010;53(3):405–11.CrossRefPubMedPubMedCentral
12.
go back to reference Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health. 2010;15 Suppl 1:1–15.CrossRefPubMedPubMedCentral Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review. Trop Med Int Health. 2010;15 Suppl 1:1–15.CrossRefPubMedPubMedCentral
13.
go back to reference Van Cutsem G, Ford N, Hildebrand K, Goemaere E, Mathee S, Abrahams M, et al. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: A cohort analysis. PLoS One. 2011;6(2):e14684.CrossRefPubMedPubMedCentral Van Cutsem G, Ford N, Hildebrand K, Goemaere E, Mathee S, Abrahams M, et al. Correcting for mortality among patients lost to follow up on antiretroviral therapy in South Africa: A cohort analysis. PLoS One. 2011;6(2):e14684.CrossRefPubMedPubMedCentral
14.
go back to reference Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet. 2006;367(9525):1870–2.CrossRefPubMed Harries AD, Schouten EJ, Libamba E. Scaling up antiretroviral treatment in resource-poor settings. Lancet. 2006;367(9525):1870–2.CrossRefPubMed
15.
go back to reference Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368(9534):505–10.CrossRefPubMed Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368(9534):505–10.CrossRefPubMed
16.
go back to reference Boulle A, Ford N. Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges? Sex Transm Infect. 2007;83(7):503–5.PubMedPubMedCentral Boulle A, Ford N. Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges? Sex Transm Infect. 2007;83(7):503–5.PubMedPubMedCentral
17.
go back to reference Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. World Health Organization, UNAIDS, UNICEF. 2010. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. World Health Organization, UNAIDS, UNICEF. 2010.
18.
go back to reference Nash D, Elul B, Rabkin M, Tun M, Saito S, Becker M, et al. Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening. J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S58–62.CrossRefPubMed Nash D, Elul B, Rabkin M, Tun M, Saito S, Becker M, et al. Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening. J Acquir Immune Defic Syndr. 2009;52 Suppl 1:S58–62.CrossRefPubMed
19.
go back to reference Morgenstern H. Ecologic studies. Modern Epidemiol. 1998;2:459–80. Morgenstern H. Ecologic studies. Modern Epidemiol. 1998;2:459–80.
21.
go back to reference Robinson WS. Ecological correlations and the behavior of individuals. Am Sociol Rev. 1950;15(3):351–7.CrossRef Robinson WS. Ecological correlations and the behavior of individuals. Am Sociol Rev. 1950;15(3):351–7.CrossRef
23.
go back to reference Breslow NE. Statistics in epidemiology: The case–control study. J Am Stat Assoc. 1996;91(433):14–28.CrossRefPubMed Breslow NE. Statistics in epidemiology: The case–control study. J Am Stat Assoc. 1996;91(433):14–28.CrossRefPubMed
24.
go back to reference White JE. A two stage design for the study of the relationship between a rare exposure and a rare disease. Am J Epidemiol. 1982;115(1):119–28.PubMed White JE. A two stage design for the study of the relationship between a rare exposure and a rare disease. Am J Epidemiol. 1982;115(1):119–28.PubMed
25.
go back to reference Scott AJ, Wild CJ. Fitting regression models to case–control data by maximum likelihood. Biometrika. 1997;84(1):57–71.CrossRef Scott AJ, Wild CJ. Fitting regression models to case–control data by maximum likelihood. Biometrika. 1997;84(1):57–71.CrossRef
26.
go back to reference Breslow NE, Holubkov R. Maximum likelihood estimation of logistic regression parameters under two-phase, outcome-dependent sampling. J R Stat Soc Ser B. 1997;59(2):447–61.CrossRef Breslow NE, Holubkov R. Maximum likelihood estimation of logistic regression parameters under two-phase, outcome-dependent sampling. J R Stat Soc Ser B. 1997;59(2):447–61.CrossRef
27.
go back to reference Wakefield J, Haneuse S. Overcoming ecologic bias using the two-phase study design. Am J Epidemiol. 2008;167(8):908–16.CrossRefPubMed Wakefield J, Haneuse S. Overcoming ecologic bias using the two-phase study design. Am J Epidemiol. 2008;167(8):908–16.CrossRefPubMed
28.
go back to reference Harries AD, Gomani P, Teck R, de Teck OA, Bakali E, Zachariah R, et al. Monitoring the response to antiretroviral therapy in resource-poor settings: The Malawi model. Trans R Soc Trop Med Hyg. 2004;98(12):695–701.CrossRefPubMed Harries AD, Gomani P, Teck R, de Teck OA, Bakali E, Zachariah R, et al. Monitoring the response to antiretroviral therapy in resource-poor settings: The Malawi model. Trans R Soc Trop Med Hyg. 2004;98(12):695–701.CrossRefPubMed
29.
go back to reference Lowrance DW, Makombe S, Harries AD, Shiraishi RW, Hochgesang M, Aberle-Grasse J, et al. A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004–2006. J Acquir Immune Defic Syndr. 2008;49(3):287–93.CrossRefPubMed Lowrance DW, Makombe S, Harries AD, Shiraishi RW, Hochgesang M, Aberle-Grasse J, et al. A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004–2006. J Acquir Immune Defic Syndr. 2008;49(3):287–93.CrossRefPubMed
30.
go back to reference Makombe SD, Hochgesang M, Jahn A, Tweya H, Hedt B, Chuka S, et al. Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ. 2008;86(4):310–4.CrossRefPubMedPubMedCentral Makombe SD, Hochgesang M, Jahn A, Tweya H, Hedt B, Chuka S, et al. Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ. 2008;86(4):310–4.CrossRefPubMedPubMedCentral
31.
go back to reference Hedt-Gauthier BL, Tenthani L, Mitchell S, Chimbwandira FM, Makombe S, Chirwa Z, et al. Improving data quality and supervision of antiretroviral therapy sites in Malawi: An application of Lot Quality Assurance Sampling. BMC Health Serv Res. 2012;12:196.CrossRefPubMedPubMedCentral Hedt-Gauthier BL, Tenthani L, Mitchell S, Chimbwandira FM, Makombe S, Chirwa Z, et al. Improving data quality and supervision of antiretroviral therapy sites in Malawi: An application of Lot Quality Assurance Sampling. BMC Health Serv Res. 2012;12:196.CrossRefPubMedPubMedCentral
32.
go back to reference McCullagh P, Nelder J. Generalized Linear Models. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC; 1989.CrossRef McCullagh P, Nelder J. Generalized Linear Models. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC; 1989.CrossRef
33.
go back to reference Breslow NE, Holubkov R. Weighted likelihood, pseudo-likelihood and maximum likelihood methods for logistic regression analysis of two-stage data. Stat Med. 1997;16(1–3):103–16.CrossRefPubMed Breslow NE, Holubkov R. Weighted likelihood, pseudo-likelihood and maximum likelihood methods for logistic regression analysis of two-stage data. Stat Med. 1997;16(1–3):103–16.CrossRefPubMed
34.
go back to reference Breslow NE, Chatterjee N. Design and analysis of two-phase studies with binary outcome applied to Wilms tumour prognosis. J R Stat Soc Ser C. 1999;48(4):457–68.CrossRef Breslow NE, Chatterjee N. Design and analysis of two-phase studies with binary outcome applied to Wilms tumour prognosis. J R Stat Soc Ser C. 1999;48(4):457–68.CrossRef
35.
go back to reference Haneuse S, Saegusa T, Lumley T: osDesign. An R Package for the Analysis, Evaluation, and Design of Two-Phase and Case–control Studies. J Stat Software 2011, 43(11). Haneuse S, Saegusa T, Lumley T: osDesign. An R Package for the Analysis, Evaluation, and Design of Two-Phase and Case–control Studies. J Stat Software 2011, 43(11).
36.
go back to reference Levy PS, Lemeshow S. Sampling of populations: methods and applications. 4th ed. Hoboken, N.J.: Wiley; 2008.CrossRef Levy PS, Lemeshow S. Sampling of populations: methods and applications. 4th ed. Hoboken, N.J.: Wiley; 2008.CrossRef
37.
go back to reference Lumley T. Complex Surveys: A Guide to Analysis Using R. Hoboken, New Jersey: John Wiley & Sons; 2010.CrossRef Lumley T. Complex Surveys: A Guide to Analysis Using R. Hoboken, New Jersey: John Wiley & Sons; 2010.CrossRef
38.
go back to reference Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M. Using the whole cohort in the analysis of case-cohort data. Am J Epidemiol. 2009;169(11):1398–405.CrossRefPubMedPubMedCentral Breslow NE, Lumley T, Ballantyne CM, Chambless LE, Kulich M. Using the whole cohort in the analysis of case-cohort data. Am J Epidemiol. 2009;169(11):1398–405.CrossRefPubMedPubMedCentral
39.
go back to reference Smoot E. Methods for effectively combining group- and individual-level data. PhD thesis. Boston: Harvard T.H. Chan School of Public Health; 2015. Smoot E. Methods for effectively combining group- and individual-level data. PhD thesis. Boston: Harvard T.H. Chan School of Public Health; 2015.
Metadata
Title
Strategies for monitoring and evaluation of resource-limited national antiretroviral therapy programs: the two-phase design
Authors
Sebastien Haneuse
Bethany Hedt-Gauthier
Frank Chimbwandira
Simon Makombe
Lyson Tenthani
Andreas Jahn
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2015
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-015-0027-9

Other articles of this Issue 1/2015

BMC Medical Research Methodology 1/2015 Go to the issue